PAXgene Urine Liquid Biopsy Set

The first verified, complete standardized preanalytical workflow that stabilizes cell-free DNA (cfDNA) in urine for subsequent analysis
 

  • Stabilization of cfDNA for various days at various temperatures minimizes post-collection cfDNA profile changes during transport and storage
     
  • User-friendly urine collection device that is convenient for individuals and laboratory professionals
     
  • Closed sample transfer into a sterile tube, minimizing microbial contamination and biospecimen exposure 
     
  • Verified with QIAGEN manual and automated cfDNA isolation technologies 
     
  • High-quality sample with unmodified cfDNA for various downstream applications

 

 

 † determined by qPCR with Investigator Quantiplex Pro RGQ Kit

Feature

Specification

Format

20 tubes: PAXgene Urine Liquid Biopsy Tube (RUO, sterile, 10 mL draw volume, 1.5 mL additive)

20 cups: PAXgene Urine Collection Cup (RUO, sterile, up to 120 mL urine volume)
Urine collection volumeUp to 120 mL per PAXgene Urine Collection Cup
Urine stabilization volume10 mL per PAXgene Urine Liquid Biopsy Tube

Tube additive volume

1.5 mL

Tube closure type/color

Yellow BD Hemogard shield with red stopper

Length of cfDNA stabilization in urine

  • up to 10 days at 15–25°C (including room temperature)
  • up to 7 days at 30°C
  • up to 3 days at 37°C
  • up to 10 days at 2–8°C
Length of cfDNA stabilization in urine supernatant in a secondary container post-centrifugation
  • up to 6 months at −20°C or −80°C (long-term study ongoing)
  • up to 3 freeze-thaw cycles at −20°C or −80°C (tested during storage of at least 7 days)
Length of cfDNA eluate* stability
  • up to 1 month at 2−8°C
  • up to 3 months at −20°C or −80°C (long-term study ongoing)
  • for up to 3 freeze-thaw cycles at −20°C or −80°C (tested during storage for 1 month)
cfDNA isolation from stabilized urine

Manual with the QIAGEN QIAamp Circulating Nucleic Acid Kit

  • 10 mL sample input volume (supplementary protocol, see Resources section below)
  • Note: Lower sample input volumes are also possible, see handbook of QIAamp Circulating Nucleic Acid Kit

 

Automated with the QIAGEN QIAsymphony Circulating DNA Kit** using the QIAGEN QIAsymphony SP Instrument 

*Isolated with the QIAamp Circulating Nucleic Acid Kit and the QIAsymphony Circulating DNA Kit**

**The QIAGEN QIAsymphony Circulating DNA Kit is not available in all countries. For further details please contact QIAGEN Technical Service 

For details regarding verification study results refer to the Performance Characteristics section of the product handbook (see Resources section below).


Intended Use

The PAXgene Urine Liquid Biopsy Set consists of a urine collection cup (PAXgene Urine Collection Cup) and a nucleic acid stabilizing tube (PAXgene Urine Liquid Biopsy Tube). It is intended for the collection, storage and transport of human urine specimen and stabilization of cell-free DNA (cfDNA) profile. The set is part of a complete preanalytical workflow for molecular testing, including the QIAGEN QIAamp Circulating Nucleic Acid Kit or the QIAGEN QIAsymphony Circulating DNA Kit.

For Research Use Only. Not for use in diagnostic procedures. The performance characteristics of this product have not been fully established.


Order information

Product

Catalog No.

Price

PAXgene Urine Liquid Biopsy Set (RUO)

Various
 

Details

Principle

 

Introduction

Cell-free DNA (cfDNA) in urine is an avenue for liquid biopsy research. In addition to being a standalone source of biomarkers, urine cfDNA has been shown to provide complementary information to blood cfDNA.

However, analysis of urine cfDNA is highly workflow dependent as shown in a research study within the EU consortium EASI Genomics††. The cfDNA profile in unstabilized urine was impacted rapidly by cfDNA degradation post collection (Figure 1A).  Furthermore, the cfDNA profile can be diluted by post collection release of genomic DNA from body cells and bacteria.

Reliable urine cfDNA analysis can only be achieved with urine stabilization (Figure 1B) integrated into a complete preanalytical workflow.

 

The PAXgene Urine Liquid Biopsy Set

The PAXgene Urine Liquid Biopsy Set, which is comprised of the PAXgene Urine Collection Cup and the PAXgene Urine Liquid Biopsy Tube, enables standardized collection and stabilization of urine specimens. Urine cfDNA is stabilized in the PAXgene Urine Liquid Biopsy Tube for various durations at various temperatures and facilitates transport and storage of urine (Figure 2).

The PAXgene Urine Collection Cup is used to collect urine. The evacuated PAXgene Urine Liquid Biopsy Tube is used to sample urine directly from the cup into the tube without the need to open the tube or the cup. Using the PAXgene Urine Liquid Biopsy Set for urine stabilization according to the handbook ensures a consistent ratio of urine to additive (Figure 3). 

The stabilized urine is compatible with QIAGEN manual and automated cfDNA isolation technologies. Please see the handbook (see Resources section below) for more details.

The isolated cfDNA eluates are compatible with various downstream technologies (Figure 2). 

 


 

Performance

The PAXgene Urine Liquid Biopsy Set is part of a complete preanalytical workflow for molecular testing including sample collection and stabilization as well as cfDNA isolation using the QIAGEN QIAamp Circulating Nucleic Acid Kit or the QIAGEN QIAsymphony Circulating DNA Kit (Figure 2). The PAXgene Urine Liquid Biopsy Set allows easy-to-use urine collection in a standard cup and closed sample transfer into a sterile tube minimizing microbial contamination and biospecimen exposure. cfDNA is stabilized by minimization of cfDNA degradation, by minimization of gDNA release and by minimization of bacterial growth over urine storage (Figure 4, 5, 6).
The additive in the tube is non-crosslinking and does not modify biomolecules like cfDNA.

Samples can be transported in a range of environments (e.g., room temperature, refrigerated or frozen (Figure 4, 5, 6). Please see the handbook (see Resources section below) for more details.

Following centrifugation and separation from cellular components, stabilized cfDNA can be isolated from the urine supernatant by manual or automated procedures using the QIAGEN QIAamp Circulating Nucleic Acid Kit or the QIAGEN QIAsymphony Circulating DNA Kit, respectively. The resulting unmodified cfDNA is of high quality (as shown using qPCR) and suitable for various downstream applications. Please see the handbook (see Resources section below) for more details.


 

Procedure

The PAXgene Urine Collection Cup is a plastic BD Vacutainer® urine collection cup for collection of up to 120 mL of urine. The evacuated PAXgene Urine Liquid Biopsy Tube contains 1.5 mL of additive and is used to sample urine directly from the PAXgene Urine Collection Cup via a needle integrated in the blue cap of the cup. The stopper of the PAXgene Urine Liquid Biopsy Tube is pierced by the needle and the vacuum in the tube enables a flow of 10 mL of urine through a straw in the PAXgene Urine Collection Cup cap.

Directly after urine collection, the unstabilized urine is transferred into the PAXgene Urine Liquid Biopsy Tube for stabilization of urine. This technology allows for convenient and safe collection and stabilization of urine with consistent ratio of urine to additive.

To stabilize more than 10 mL of urine, multiple PAXgene Urine Liquid Biopsy Tubes can be filled from the same cup depending on the total volume of urine collected into the cup.

 


 

Applications

Compatible with various assay technologies, e.g., dPCR and qPCR. Please see the handbook (see Resources section below) for more details.

 

Further downstream applications with urine

See externally conducted research studies from Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer using the PAXgene Liquid Biopsy technology with next-generation sequencing (NGS).

 


 

Figure 1 depicts the yield of spiked male urine cfDNA in female urine, either unstabilized (A) or stabilized with the PAXgene Urine Liquid Biopsy technology (B) during room temperature (15-25°C) storage from 1 hour (h) and up to 72h post urine collection. Data are presented relative to urine processed within 1h of urine collection (set to 1). cfDNA was isolated with the QIAsymphony SP instrument  and analyzed on the QIAGEN RGQ instrument. Data include urine from 4 individuals. Mean and SD are denoted. Data was generated within a research study of the EASI-Genomics consortium††.

Figure 1: Change in cfDNA yield during storage of unstabilized and stabilized urine

Figure 1 depicts the yield of spiked male urine cfDNA in female urine, either ...
The PAXgene Urine Liquid Biopsy Set is part of a complete preanalytical workflow for molecular testing

Figure 2: PAXgene Urine Liquid Biopsy Set workflow

The PAXgene Urine Liquid Biopsy Set is part of a complete preanalytical workflow ...

Figure 3: Handling of the PAXgene Urine Liquid Biopsy Set after urine collection

Figure 4 depicts the yield of spiked male urine cfDNA in female urine stabilized with the PAXgene Urine Liquid Biopsy Tube after urine storage (Tx; where x equals 3, 7, or 10 days storage) relative to stabilized urine processed within 4 hours of urine collection (T0, set to 1). cfDNA was isolated with the QIAsymphony DSP Circulating DNA Kit and analyzed with the Investigator Quantiplex Pro RGQ assay. Data include 4 urine pools with 3 qPCR replicates. Mean and SD are denoted.

Figure 4: cfDNA stabilization by minimization of degradation during whole urine storage

Figure 4 depicts the yield of spiked male urine cfDNA in female urine stabilized ...
Figure 5 depicts the yield of an autosomal qPCR target in urine stabilized with the PAXgene Urine Liquid Biopsy Tube after urine storage (Tx, where x equals 3, 7, or 10 days storage) relative to stabilized urine processed within 4 hours of urine collection (T0, set to 1). cfDNA was isolated with the QIAsymphony DSP Circulating DNA Kit and analyzed with the Investigator Quantiplex Pro RGQ assay. Data include 8 urine pools with 3 qPCR replicates. n = 24. Mean and SD are denoted.

Figure 5: cfDNA stabilization by minimization of gDNA release during whole urine storage

Figure 5 depicts the yield of an autosomal qPCR target in urine stabilized with ...
Figure 6 depicts the yield of bacterial DNA (16S qPCR target) in urine stabilized with the PAXgene Urine Liquid Biopsy Tube after urine storage (Tx, where x equals 3, 7, or 10 days storage) relative to stabilized urine processed within 4 hours of urine collection (T0, set to 1). cfDNA was isolated with the QIAsymphony DSP Virus/Pathogen Kit and analyzed on the Rotor-Gene Q real-time PCR cycler. Data include 6 to 8 urine pools with 3 qPCR replicates. n = 18–24. Mean and SD are denoted.

Figure 6: cfDNA stabilization by minimization of bacterial growth during whole urine storage

Figure 6 depicts the yield of bacterial DNA (16S qPCR target) in urine stabilized ...

Resources

Other Products Used in Conjunction


Need Help?

Product Information

For details about our products, reach out 
to our Global Contacts.

Technical Assistance

For troubleshooting or technical inquiries, 
get in touch with Technical Service.

Order Support

For help with placing or tracking an order, 
contact Customer Care.